REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study

NCT06041386 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

336

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Mepolizumab
OTHER: Spirometry

Sponsor

GlaxoSmithKline